Encapsulation of bovine serum albumin within β-cyclodextrin/gelatin-based polymeric hydrogel for controlled protein drug release

IRBM ◽  
2010 ◽  
Vol 31 (4) ◽  
pp. 234-241 ◽  
Author(s):  
A.A. Haroun ◽  
N.R. El-Halawany
2021 ◽  
Author(s):  
Tahmineh Atloo ◽  
Ramin Mohammadkhani ◽  
Ali Mohammadi ◽  
Kasra Arbabi Zaboli ◽  
Saeed Kaboli ◽  
...  

Abstract In this work, first, copper oxide nanoparticles (CUO NPs) were synthesized by physical methods and then coated with the bovine serum albumin (BSA) via biologically meditated minerals to form CUO@BSA NPs. Finally, curcumin (CUR) as an anticancer drug were immobilized on the surface of CUO@BSA NPS. The properties of CUO@BSA-CUR NPS were investigated by FTIR, UV-Vis, TEM, and AFM spectroscopes. It was found that the synthesized CUO@BSA-CUR nanoparticles were spherical with a particle size of 20 to 30 nm and have a sustained release of CUR at 37°C in buffer solution. Also, the result of release in biological environment showed that maximum drug release rate for this nanocarrier in pH 7.4 was measured 75% after 48 hours. The cytotoxicity of CUO@BSA-CUR on MDA-MB-231 cell line was studied. The results showed that CUO@BSA-CUR nanoparticles have significant cytotoxic activity on this cell line, while the results of MTT assay indicated the CUO@BSA NPs have no toxicity effect on the cancer cells.


2019 ◽  
Vol 43 (6) ◽  
pp. 2694-2701 ◽  
Author(s):  
Yuan Zhang ◽  
Yang Xing ◽  
Ming Xian ◽  
Shaomin Shuang ◽  
Chuan Dong

A targeted DDS with covalently conjugated BSA and folate for GSH-triggered drug release and recognition of FR-positive cancer cells.


Sign in / Sign up

Export Citation Format

Share Document